| IGKV3-20 |
P01619
|
immunoglobulin kappa variable 3-20
|
Immune response
|
|
0.736 |
0.308 |
| DLX2 |
Q07687
|
distal-less homeobox 2
|
Transcription factor
|
0.98 |
0.711 |
0.423 |
| CD52 |
P31358
|
CD52 molecule
|
|
0.40 |
0.615 |
0.500 |
| TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
| TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
| IBTK |
Q9P2D0
|
inhibitor of Bruton tyrosine kinase
|
|
2.2E-03 |
0.678 |
0.538 |
| PRAME |
P78395
|
preferentially expressed antigen in melanoma
|
|
2.4E-07 |
0.531 |
0.577 |
| MCU |
Q8NE86
|
mitochondrial calcium uniporter
|
Ion channel
|
0.83 |
0.670 |
0.577 |
| CD22 |
P20273
|
CD22 molecule
|
|
0.80 |
0.556 |
0.615 |
| SLAMF1 |
Q13291
|
signaling lymphocytic activation molecule family member 1
|
|
7.0E-03 |
0.612 |
0.615 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| CDK2 |
P24941
|
cyclin dependent kinase 2
|
Kinase
|
0.61 |
0.456 |
0.692 |
| SPN |
P16150
|
sialophorin
|
|
1.4E-02 |
0.563 |
0.692 |
| BCL3 |
P20749
|
BCL3 transcription coactivator
|
|
0.99 |
0.541 |
0.731 |
| CDK6 |
Q00534
|
cyclin dependent kinase 6
|
Kinase
|
0.98 |
0.471 |
0.731 |
| CCR4 |
P51679
|
C-C motif chemokine receptor 4
|
G-protein coupled receptor
|
6.9E-02 |
0.510 |
0.731 |
| ETV6 |
P41212
|
ETS variant transcription factor 6
|
Transcription factor
|
0.97 |
0.477 |
0.731 |
| JAK3 |
P52333
|
Janus kinase 3
|
Kinase
|
5.9E-06 |
0.505 |
0.731 |
| MTX1 |
Q13505
|
metaxin 1
|
|
1.3E-02 |
0.546 |
0.731 |
| PSMB6 |
P28072
|
proteasome 20S subunit beta 6
|
|
1.6E-02 |
0.561 |
0.731 |
| TNFSF13B |
Q9Y275
|
TNF superfamily member 13b
|
|
0.98 |
0.460 |
0.731 |
| MARCKSL1 |
P49006
|
MARCKS like 1
|
|
1.4E-02 |
0.508 |
0.731 |
| WLS |
Q5T9L3
|
Wnt ligand secretion mediator
|
|
2.0E-02 |
0.513 |
0.731 |
| ANPEP |
P15144
|
alanyl aminopeptidase, membrane
|
Enzyme
|
3.7E-09 |
0.462 |
0.769 |
| CBL |
P22681
|
Cbl proto-oncogene
|
Enzyme
|
6.1E-04 |
0.527 |
0.769 |